quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 4, 2026

ServiceNow Partnerships Deepen AI Workflow Role Across Supply Chain And HR

View original at finance.yahoo.com
ServiceNow Partnerships Deepen AI Workflow Role Across Supply Chain And HR Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • These are deep, system-of-record style integrations rather than one-off point tools

    60% confidence

  • ServiceNow aims to be an AI workflow platform at the center of large enterprises

    60% confidence

  • ServiceNow is being used as a common control layer for AI-powered workflows across supply chain, IT operations, security and HR

    60% confidence

  • ServiceNow sits at the center of a broad shift toward platforms that connect workflows across IT, operations, and business functions

    60% confidence

  • Expanding into more complex workflows in supply chain and multi function HR systems could test execution, a risk for new AI heavy use cases

    60% confidence

  • ServiceNow is being adopted as an AI-driven enterprise platform by new ecosystem partners and customers

    60% confidence

  • These are not lightweight plug-ins but full deployments aimed at coordinating real-world processes such as logistics, employee services, and IT incidents

    60% confidence

Data points we hold from this source

ServiceNow · risk count0 count
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
ServiceNow Partnerships Deepen AI Workflow Role Across Supply Chain And HR — Source | Via News | pt.VIA.NEWS